Codify — Article

California AB 2123: Licensing, care-continuity, and dispute rules for health plans

Clarifies facility/personnel licensure, recognizes telehealth for regulatory compliance, requires provider-friendly dispute processes and preserves clinical decision-making protections — shifting oversight and administrative duties onto plans.

The Brief

AB 2123 tightens statutory requirements for health care service plans operating in California. It requires in‑state facilities used by a plan to hold the applicable State Department of Public Health licenses, requires personnel and certain equipment to be properly licensed or certified, treats appropriately provided telehealth as counting toward regulatory compliance, and obliges plans to demonstrate that medical decisions are made by qualified clinicians without improper fiscal or administrative interference.

The bill also imposes contract-level rules: provider contracts must include a fast, fair, cost‑effective dispute-resolution mechanism; the mechanism must be accessible to noncontracting providers for billing and claims disputes; and plans must report annually to the department on dispute usage and outcomes. AB 2123 preserves plan obligations when services are delegated to medical groups or IPAs and bars plans from conditioning optometrist participation on federal controlled‑substances registration in certain circumstances.

These provisions increase regulatory clarity for providers and enrollees while adding operational and reporting duties for plans and their contractors.

At a Glance

What It Does

Requires that facilities, personnel, and regulated equipment used by a health care service plan be properly licensed or certified; counts telehealth when appropriate for compliance with Title 28 regulations; mandates dispute-resolution provisions in provider contracts and access for noncontracting providers; requires annual reporting on disputes; and preserves plan obligations when delegating services.

Who It Affects

California-regulated health care service plans (including specialized plans), their provider networks and contracting entities (medical groups, IPAs), noncontracting providers who submit billing or claims, optometrists certified to use therapeutic pharmaceuticals, and the state department charged with oversight.

Why It Matters

The bill clarifies regulator expectations on licensing, access, and clinical decision‑making, formalizes procedural protections for providers, and creates new administrative and reporting responsibilities for plans — shifting where compliance effort and potential liability land.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

AB 2123 reorganizes and reaffirms baseline obligations for health care service plans in California. At the facility level it insists that any in‑state clinic, hospital, or skilled nursing facility used by a plan hold the licenses required by the State Department of Public Health, while out‑of‑state facilities must meet their local licensing rules.

The statute also requires that any personnel or equipment that by law must be licensed or registered meet those credentialing requirements before providing services under a plan.

On access and care delivery, the bill emphasizes continuity of care and ready referral to other providers, and it makes an explicit regulatory connection between telehealth and an existing Title 28 compliance standard: where telehealth is appropriate, those services count toward meeting the regulation cited in the statute. The plan must ensure services are available at reasonable times and be accessible to enrollees consistent with other statutory sections the bill references.The bill tightens contract and dispute mechanics.

Every provider contract must include a fast, fair, cost‑effective dispute-resolution process, with the plan required to inform providers about how to raise disputes. Importantly, the dispute mechanism must also be available to noncontracting providers for billing and claims disputes, and plans must submit an annual report to the department detailing usage and the disposition of disputes.AB 2123 also protects certain provider participation conditions: it prohibits plans from requiring federal Controlled Substances Act registration as a condition for participation by optometrists certified to use therapeutic pharmaceutical agents under state law.

Finally, the bill clarifies that a plan’s statutory obligations cannot be waived when it delegates services to medical groups, IPAs, or other contracting entities — meaning the plan remains on the hook for compliance even when it outsources performance.

The Five Things You Need to Know

1

The bill requires in‑state facilities used by a health plan to hold the licenses required by the State Department of Public Health, and requires out‑of‑state facilities to meet their own jurisdiction’s licensing rules.

2

Telehealth services, when appropriately provided, count toward compliance with Section 1300.67.2 of Title 28 of the California Code of Regulations.

3

Provider contracts must include a fast, fair, cost‑effective dispute resolution mechanism and the plan must notify providers of the procedures and contact information.

4

The dispute resolution mechanism must be accessible to noncontracting providers for billing and claims disputes, and plans must submit an annual report to the department showing how many providers used the mechanism and the dispositions of those disputes.

5

A plan cannot avoid its statutory obligations by delegating required services to medical groups, independent practice associations, or other contracting entities.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Subdivision (a)

Facility licensure: in‑state requirement; out‑of‑state conformity

This provision obligates plans to use facilities that are licensed by the State Department of Public Health whenever state law requires licensure. For any facility located outside California, the plan must ensure the facility complies with the licensing and other legal requirements of its jurisdiction. Practically, plans must institute credentialing processes that capture both state licensing for in‑state providers and equivalent confirmations for out‑of‑state partners, which affects network participation criteria and vendor contracting.

Subdivisions (b) and (c)

Personnel and equipment credentialing

The bill requires that personnel employed by or contracted to the plan hold whatever licenses or certifications state law mandates, and that equipment requiring registration or licensing be properly registered with licensed operators. This places a clear compliance duty on plans to verify individual clinician credentials and equipment permits, not just on the provider entities, increasing documentation and audit trails for credentialing teams.

Subdivisions (d), (e), and (f)

Continuity, access, and telehealth recognition

Plans must furnish services in a way that preserves continuity of care and makes appropriate referrals. Services must be reasonably available at reasonable times; the statute expressly directs plans to make services accessible consistent with related sections. It adds that where telehealth is an appropriate modality, those encounters should be counted when assessing compliance with the named Title 28 regulatory standard, which may affect network adequacy reviews and access metrics used by regulators.

4 more sections
Subdivision (g)

Clinical decision‑making must be by qualified providers, free from fiscal interference

This section requires plans to demonstrate to the department that medical decisions are rendered by qualified providers and are not impeded by fiscal or administrative management. That is an evidentiary obligation: plans need policies, documentation, or processes showing clinical autonomy. It signals regulator scrutiny of utilization management, financial incentives, and administrative barriers that might in practice constrain clinician judgment.

Subdivision (h)

Contract provisions, dispute resolution, and reporting

Contracts with enrollees, providers, and other vendors must be fair and consistent with the chapter’s objectives. All provider contracts must contain a dispute-resolution mechanism that is fast, fair, and cost‑effective; the plan must notify providers of the process and where to submit disputes. The provision extends access to this mechanism to noncontracting providers specifically for billing and claims disputes and requires that plans annually report to the department on dispute usage and dispositions, creating a recurring transparency obligation.

Subdivision (i) and cost sharing language

Basic health services and cost‑sharing disclosure

The bill reiterates that plan contracts must provide the basic health care services identified elsewhere in statute, subject to any director exemptions, and permits plans to charge copayments or deductibles consistent with specified sections so long as cost‑sharing is reported and disclosed to enrollees. This keeps the director’s disclosure regime intact while preserving limited flexibility for plans on cost sharing.

Subdivisions (j) and (l)

Optometrist participation and non‑waivable obligations when delegating

The statute prohibits plans from conditioning an optometrist’s participation on registration under the federal Controlled Substances Act if that registration is not required by the state scope of practice for therapeutic pharmaceutical agents. It also states a plan cannot escape its statutory duties by delegating required services to medical groups, IPAs, or other contractors, making the plan legally responsible for compliance even when it contracts out service delivery.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Enrollees and patients — clearer expectations for licensed facilities and continuity of care improve access safeguards and make regulatory recourse more practical.
  • Noncontracting providers — explicit access to the plan’s dispute-resolution process for billing and claims disputes provides a formal channel for resolving payment conflicts.
  • Optometrists certified to use therapeutic pharmaceutical agents — the bill bars plans from conditioning participation on federal CSA registration in specified circumstances, protecting scope‑of‑practice participation.
  • State regulator(s) — the department gains standardized reporting (annual dispute reports) and an explicit statutory hook to review whether clinical decisions are free from administrative interference.

Who Bears the Cost

  • Health care service plans and their compliance teams — implementing and documenting licensure checks, telehealth compliance assessments, dispute-resolution systems, and annual reporting will increase administrative workload and likely costs.
  • Medical groups, IPAs, and provider contracting entities — because delegation doesn't waive the plan’s obligations, these organizations may face tighter contractual obligations and closer oversight by plans seeking to demonstrate compliance.
  • Small or niche plans and vendor partners — establishing fast, fair, cost‑effective dispute systems and maintaining certification audits may be disproportionately costly for smaller operators.
  • The department — the new reporting and demonstration requirements may require expanded oversight capacity and impose a review burden on regulators unless resourced.

Key Issues

The Core Tension

The bill pits two legitimate objectives against each other: protecting clinical independence and patient access on one side, and allowing health plans to manage utilization, costs, and contractual networks on the other. Strengthening provider protections and dispute access improves safeguards for care, but it increases administrative demands and could limit plans’ ability to implement cost controls — a trade‑off regulators and stakeholders will have to balance in implementation.

Several implementation questions could drive litigation or require detailed regulatory guidance. First, the phrase requiring plans to “demonstrate” that medical decisions are rendered by qualified providers and are “unhindered by fiscal and administrative management” raises evidentiary and operational issues: regulators will need objective benchmarks or documentary standards (policies, appeal outcomes, utilization review practices) to evaluate compliance.

Without those, enforcement risks arbitrariness and may prompt disputes over what constitutes prohibited interference.

Second, granting noncontracting providers access to a plan’s dispute-resolution mechanism for billing and claims disputes expands procedural protections but creates potential operational friction: plans may face increased volume of disputes, higher administrative costs, and more contested claim reviews. The annual reporting mandate will make dispute activity visible, but it may also incentivize gaming (e.g., classifying resolutions to show favorable dispositions) unless the department prescribes reporting detail and audit rights.

Third, the bill’s cross‑references to existing regulations (for example, Title 28 compliance) and lingering or misdated language (an unchanged January 1, 2002 reference appears in the text) suggest drafting cleanup may be needed to avoid confusion about which regulatory standards and effective dates apply. Lastly, tension between preserving clinical autonomy and allowing plans to design utilization and cost‑control programs remains unresolved: stronger protections for clinician decision‑making could constrain some prior utilization management practices, requiring careful calibration in regulations or guidance.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.